BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8895247)

  • 21. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agent.
    Seguin L; Le Marouille-Girardon S; Millan MJ
    Pain; 1995 May; 61(2):325-343. PubMed ID: 7659444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of non-peptide tachykinin receptor antagonists to substantiate the involvement of NK1 and NK2 receptors in a spinal nociceptive reflex in the rat.
    Picard P; Boucher S; Regoli D; Gitter BD; Howbert JJ; Couture R
    Eur J Pharmacol; 1993 Mar; 232(2-3):255-61. PubMed ID: 7682180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterisation of NK1 receptor antagonist, [D-Trp7]sendide, on behaviour elicited by substance P in the mouse.
    Sakurada T; Yogo H; Manome Y; Tan-No K; Sakurada S; Yamada A; Kisara K; Ohba M
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):387-92. PubMed ID: 7531295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anxiolytic effect of NKP608, a NK1-receptor antagonist, in the social investigation test in gerbils.
    Gentsch C; Cutler M; Vassout A; Veenstra S; Brugger F
    Behav Brain Res; 2002 Jul; 133(2):363-8. PubMed ID: 12110470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils.
    Rupniak NM; Webb JK; Fisher A; Smith D; Boyce S
    Neuropharmacology; 2003 Mar; 44(4):516-23. PubMed ID: 12646288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret.
    Singh L; Field MJ; Hughes J; Kuo BS; Suman-Chauhan N; Tuladhar BR; Wright DS; Naylor RJ
    Eur J Pharmacol; 1997 Feb; 321(2):209-16. PubMed ID: 9063690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tachykinin receptor inhibition and c-Fos expression in the rat brain following formalin-induced pain.
    Baulmann J; Spitznagel H; Herdegen T; Unger T; Culman J
    Neuroscience; 2000; 95(3):813-20. PubMed ID: 10670449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for tonic activation of NK-1 receptors during the second phase of the formalin test in the Rat.
    Henry JL; Yashpal K; Pitcher GM; Chabot J; Coderre TJ
    J Neurosci; 1999 Aug; 19(15):6588-98. PubMed ID: 10414986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Volume transmission of substance P in striatum induced by intraplantar formalin injection attenuates nociceptive responses via activation of the neurokinin 1 receptor.
    Nakamura Y; Izumi H; Shimizu T; Hisaoka-Nakashima K; Morioka N; Nakata Y
    J Pharmacol Sci; 2013; 121(4):257-71. PubMed ID: 23514787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tachykinin receptors mediate atropine-resistant rat duodenal reflex contractions in vivo.
    Giuliani S; Tramontana M; Lecci A; Maggi CA
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):327-35. PubMed ID: 8878063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
    Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1 ) receptor in assays for antidepressant and anxiolytic drugs.
    Rupniak NM; Carlson EJ; Webb JK; Harrison T; Porsolt RD; Roux S; de Felipe C; Hunt SP; Oates B; Wheeldon A
    Behav Pharmacol; 2001 Nov; 12(6-7):497-508. PubMed ID: 11742144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in the effects of NK1-receptor antagonists, (+/-)-CP 96,345 and CP 99,994, on agonist-induced responses in guinea-pig trachea.
    Longmore J; Razzaque Z; Shaw D; Hill RG
    Br J Pharmacol; 1994 May; 112(1):176-8. PubMed ID: 7518303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of both NK1 and NK2 receptors in guinea-pig airways.
    McKee KT; Millar L; Rodger IW; Metters KM
    Br J Pharmacol; 1993 Oct; 110(2):693-700. PubMed ID: 7694756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SR 140333, a novel, selective, and potent nonpeptide antagonist of the NK1 tachykinin receptor: characterization on the U373MG cell line.
    Oury-Donat F; Lefevre IA; Thurneyssen O; Gauthier T; Bordey A; Feltz P; Emonds-Alt X; Le Fur G; Soubrie P
    J Neurochem; 1994 Apr; 62(4):1399-407. PubMed ID: 7510780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The non-peptide NK1 receptor antagonist SR140333 produces long-lasting inhibition of neurogenic inflammation, but does not influence acute chemo- or thermonociception in rats.
    Amann R; Schuligoi R; Holzer P; Donnerer J
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):201-5. PubMed ID: 7477444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Centrally administered hemokinin-1 (HK-1), a neurokinin NK1 receptor agonist, produces substance P-like behavioral effects in mice and gerbils.
    Duffy RA; Hedrick JA; Randolph G; Morgan CA; Cohen-Williams ME; Vassileva G; Lachowicz JE; Laverty M; Maguire M; Shan LS; Gustafson E; Varty GB
    Neuropharmacology; 2003 Aug; 45(2):242-50. PubMed ID: 12842130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of a tachykinin NK1 receptor antagonist, SR140333, on oedema formation induced in rat skin by venom from the Phoneutria nigriventer spider.
    Palframan RT; Costa SK; Wilsoncroft P; Antunes E; de Nucci G; Brain SD
    Br J Pharmacol; 1996 May; 118(2):295-8. PubMed ID: 8735630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin.
    Dougherty PM; Palecek J; Palecková V; Willis WD
    J Neurophysiol; 1994 Oct; 72(4):1464-75. PubMed ID: 7823080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.